ArticleJournal of cellular and molecular medicine2022

Screening by high-throughput sequencing for pathogenic variants in cystic fibrosis: Benefit of introducing personalized therapies.

Ana Cristina Vieira de Melo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.